Skip to main content

Advertisement

SpringerLink
Log in

Clinical Trials Reports

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. National Institute of Diabetes and Digestive and Kidney Diseases: National Diabetes Statistics Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2003. Bethesda, MD: U.S. Department of Health and Human Services, National Institute of Health; 2003.

    Google Scholar 

  2. El-Atat F, McFarlane SI, Sowers JR: Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management. Curr Hypertens Rep 2004, 6:215—223.

    PubMed  Google Scholar 

  3. Staessen JA, Wang JG, Thijs L: Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001, 358:1305—1315.

    PubMed  Google Scholar 

  4. McFarlane SI, Jacober SJ, Winer N, et al.: Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. Diabetes Care 2002, 25:718—723.

    Article  PubMed  Google Scholar 

  5. Pepine CJ, Handberg EM, Cooper-DeHoff RM, et al., for INVEST Investigators: A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease: The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial. JAMA 2003, 290:2805—2816.

    Article  PubMed  Google Scholar 

  6. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The Sixth Report of Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997, 157:2413—2446.

    Google Scholar 

  7. Writing Group for the Women’s Health Initiative Investigators: Risk and benefits of estrogen and progestin in healthy postmenopausal women. JAMA 2002, 288:321—333.

    Article  Google Scholar 

  8. Yusuf S, Sleight P, Pogue J, et al., The Heart Outcomes Prevention Evaluation Study Investigators: Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000, 342:145—153.

    PubMed  Google Scholar 

  9. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin converting enzyme inhibitor or calcium channel blockers vs diuretics. JAMA 2002, 288:2981—2997.

    Google Scholar 

  10. Black HR, Elliott WJ, Grandits G, et al., for the CONVINCE Research Group: Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial. JAMA 2003, 289:2073—2082.

    Article  PubMed  Google Scholar 

  11. Cruickshank J: The J-curve in hypertension. Curr Cardiol Rep 2003, 5:441—452.

    Article  PubMed  Google Scholar 

  12. McFarlane SI, Farag A, Sowers J: Calcium antagonists in patients with type 2 diabetes and hypertension. Cardiovasc Drug Rev 2003, 21:105—118.

    PubMed  Google Scholar 

Download references

Authors
  1. Surender Arora MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John Nicasio DO
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Samy I. McFarlane MD, MPH, FACP
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arora, S., Nicasio, J. & McFarlane, S.I. Clinical Trials Reports. Current Science Inc 7, 201–203 (2005). https://doi.org/10.1007/s11906-005-0010-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-005-0010-7

Keywords

Search

Navigation